Purple Biotech LtdNASDAQ:PPBTNASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE0.5160
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.5000/ 5
- Ask / Lots0.5880/ 5
- Open / Previous Close0.0000 / 0.5160
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | PPBT |
|---|---|---|
| 09:32 ET | 974 | 0.534 |
| 09:34 ET | 7098 | 0.558 |
| 09:36 ET | 20160 | 0.552 |
| 09:38 ET | 23470 | 0.5499 |
| 09:39 ET | 500 | 0.507918 |
| 09:41 ET | 400 | 0.5332 |
| 09:43 ET | 500 | 0.5332 |
| 09:45 ET | 2867 | 0.5332 |
| 09:48 ET | 4271 | 0.536701 |
| 09:50 ET | 1500 | 0.5367 |
| 09:52 ET | 567 | 0.534 |
| 09:54 ET | 8234 | 0.5339 |
| 09:56 ET | 2787 | 0.52975 |
| 09:57 ET | 968 | 0.5298 |
| 09:59 ET | 3300 | 0.534 |
| 10:01 ET | 23738 | 0.5401 |
| 10:03 ET | 5461 | 0.555 |
| 10:06 ET | 490 | 0.563131 |
| 10:08 ET | 3371 | 0.55 |
| 10:10 ET | 103 | 0.55 |
| 10:12 ET | 425 | 0.564 |
| 10:14 ET | 300 | 0.564 |
| 10:15 ET | 1250 | 0.563999 |
| 10:17 ET | 6166 | 0.5642 |
| 10:19 ET | 13345 | 0.569 |
| 10:21 ET | 34129 | 0.5818 |
| 10:24 ET | 16460 | 0.5848 |
| 10:26 ET | 24197 | 0.54 |
| 10:28 ET | 114133 | 0.5361 |
| 10:30 ET | 10652 | 0.533 |
| 10:32 ET | 46984 | 0.558 |
| 10:33 ET | 14825 | 0.5351 |
| 10:35 ET | 9873 | 0.54 |
| 10:37 ET | 183 | 0.54 |
| 10:39 ET | 6019 | 0.5402 |
| 10:42 ET | 900 | 0.5518 |
| 10:44 ET | 183 | 0.5455 |
| 10:46 ET | 1900 | 0.551 |
| 10:48 ET | 4420 | 0.54 |
| 10:50 ET | 2369 | 0.5482 |
| 10:51 ET | 3103 | 0.537 |
| 10:55 ET | 1767 | 0.54 |
| 10:57 ET | 1500 | 0.5455 |
| 11:00 ET | 4047 | 0.54 |
| 11:02 ET | 605 | 0.5448 |
| 11:04 ET | 8600 | 0.5398 |
| 11:06 ET | 3444 | 0.53495 |
| 11:08 ET | 9478 | 0.5301 |
| 11:09 ET | 4446 | 0.521495 |
| 11:15 ET | 798 | 0.539 |
| 11:20 ET | 350 | 0.5362 |
| 11:24 ET | 500 | 0.5389 |
| 11:26 ET | 543 | 0.53 |
| 11:36 ET | 1882 | 0.526 |
| 11:40 ET | 330 | 0.532999 |
| 11:42 ET | 1000 | 0.545 |
| 11:44 ET | 12671 | 0.52 |
| 11:45 ET | 100 | 0.5325 |
| 11:47 ET | 5741 | 0.52 |
| 11:49 ET | 100 | 0.5293 |
| 11:51 ET | 9682 | 0.5131 |
| 11:54 ET | 2500 | 0.54 |
| 11:58 ET | 100 | 0.5387 |
| 12:02 ET | 12646 | 0.53 |
| 12:09 ET | 2721 | 0.5102 |
| 12:12 ET | 114 | 0.526001 |
| 12:18 ET | 1574 | 0.54 |
| 12:20 ET | 100 | 0.53 |
| 12:34 ET | 400 | 0.528 |
| 12:39 ET | 100 | 0.52 |
| 12:43 ET | 23431 | 0.51 |
| 12:45 ET | 16803 | 0.5 |
| 12:48 ET | 100 | 0.5 |
| 12:50 ET | 6110 | 0.5 |
| 12:52 ET | 4029 | 0.4901 |
| 12:54 ET | 400 | 0.4999 |
| 12:56 ET | 11334 | 0.5 |
| 12:57 ET | 600 | 0.4999 |
| 01:08 ET | 300 | 0.495 |
| 01:12 ET | 5150 | 0.495 |
| 01:14 ET | 1359 | 0.4999 |
| 01:24 ET | 5000 | 0.4995 |
| 01:26 ET | 800 | 0.495 |
| 01:35 ET | 440 | 0.4998 |
| 01:37 ET | 100 | 0.49 |
| 01:55 ET | 100 | 0.49495 |
| 02:02 ET | 4714 | 0.494949 |
| 02:04 ET | 110 | 0.494951 |
| 02:06 ET | 624 | 0.49 |
| 02:08 ET | 1500 | 0.4999 |
| 02:09 ET | 1000 | 0.4901 |
| 02:11 ET | 2000 | 0.498325 |
| 02:13 ET | 1450 | 0.49 |
| 02:15 ET | 11600 | 0.4998 |
| 02:20 ET | 700 | 0.4999 |
| 02:22 ET | 6607 | 0.5001 |
| 02:24 ET | 133 | 0.5001 |
| 02:29 ET | 880 | 0.5001 |
| 02:40 ET | 400 | 0.5 |
| 02:51 ET | 100 | 0.5001 |
| 02:54 ET | 398 | 0.49 |
| 03:00 ET | 2787 | 0.4999 |
| 03:02 ET | 125 | 0.495 |
| 03:05 ET | 5000 | 0.499801 |
| 03:09 ET | 1965 | 0.5001 |
| 03:12 ET | 200 | 0.499613 |
| 03:18 ET | 250 | 0.499595 |
| 03:20 ET | 200 | 0.5001 |
| 03:27 ET | 1200 | 0.5 |
| 03:32 ET | 735 | 0.5001 |
| 03:41 ET | 120 | 0.525 |
| 03:43 ET | 253 | 0.53 |
| 03:45 ET | 100 | 0.5005 |
| 03:48 ET | 15548 | 0.49 |
| 03:50 ET | 1700 | 0.49 |
| 03:52 ET | 2000 | 0.4901 |
| 03:54 ET | 5085 | 0.4901 |
| 03:56 ET | 1000 | 0.497753 |
| 03:57 ET | 1700 | 0.49 |
| 03:59 ET | 1100 | 0.512 |
Yesterday
Mar 28, 2024
Purple Biotech to Present New Data On its Oncology Drug NT219 at AACR 2024, from 7:00AM ET on Thursday Mar 28, 2024 by Dow Jones
7:00AM ET on Thursday Mar 28, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Purple Biotech Ltd | 14.7M | -0.6x | --- |
Inhibitor Therapeutics Inc | 14.8M | -4.9x | --- |
Edesa Biotech Inc | 14.4M | -1.7x | --- |
NeuroBo Pharmaceuticals Inc | 15.0M | -1.1x | --- |
Vaxxinity Inc | 15.4M | -0.3x | --- |
Cardio Diagnostics Holdings Inc | 15.6M | -1.0x | --- |
Company Information
Purple Biotech Ltd, formerly Kitov Pharma Ltd, is an Israel-based clinical-stage company that develops drugs that overcome tumor-immune evasion and drug resistancetreat pain. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The Company is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.
Contact Information
- Headquarters
- 4 Oppenheimer St., Science ParkREHOVOT, Israel 7670104
- Phone
- ---
- Fax
- ---
Executives
- Chairman of the Board
- Eric Rowinsky
- Chief Executive Officer & Director
- Itzhak Israel
- Deputy Chief Executive Officer, Chief Financial Officer
- Gil Efron
- Vice President - Business Development
- Gil Ben-Menachem
- General Counsel, Secretary
- Avraham Ben-Tzvi
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $14.7M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 26.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.01 |
EPS | $-0.85 |
Book Value | $1.36 |
P/E Ratio | -0.6x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
